What are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified delphi process
about
Making rational choices about how best to support consumers' use of medicines: a perspective reviewMethodology for Developing Deprescribing Guidelines: Using Evidence and GRADE to Guide Recommendations for DeprescribingDevelopmental evaluation as a strategy to enhance the uptake and use of deprescribing guidelines: protocol for a multiple case study.Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline.Clinician agreement and influence of medication-related characteristics on assessment of polypharmacyReducing Polypharmacy from the Perspectives of General Practitioners and Older Patients: A Synthesis of Qualitative Studies.Challenges and Enablers of Deprescribing: A General Practitioner Perspective.Effectiveness of Interventions to Deprescribe Inappropriate Proton Pump Inhibitors in Older Adults.Clinically important drug-drug interactions in poly-treated elderly outpatients: a campaign to improve appropriateness in general practice.What factors are important for deprescribing in Australian long-term care facilities? Perspectives of residents and health professionals.The potential for deprescribing in care home residents with Type 2 diabetesThe Variation of Statin Use Among Nursing Home Residents and Physicians: A Cross-Sectional Analysis.Deprescribing: An Application to Medication Management in Older Adults.Novel tool for deprescribing in chronic patients with multimorbidity: List of Evidence-Based Deprescribing for Chronic Patients criteria.Swimming Against the Tide: Primary Care Physicians' Views on Deprescribing in Everyday Practice.Déprescrire les inhibiteurs de la pompe à protons: Lignes directrices de pratique clinique fondées sur les données probantes.Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: Evidence-based clinical practice guideline.Withdrawal of Antidementia Drugs in Older People: Who, When and How?Use of antipsychotics and benzodiazepines for dementia: Time for action? What will be required before global de-prescribing?Déprescription des antipsychotiques pour les symptômes comportementaux et psychologiques de la démence et l’insomnie: Guide de pratique clinique fondé sur des données probantes.An Ecological Approach to Reducing Potentially Inappropriate Medication Use: Canadian Deprescribing Network.Association of Parkinsonism or Parkinson Disease with Polypharmacy in the Year Preceding Diagnosis: A Nested Case-Control Study in South Korea.Deprescribing benzodiazepine receptor agonists: Evidence-based clinical practice guideline.Déprescription des agonistes des récepteurs des benzodiazépines: Lignes directrices de pratique clinique fondées sur les données probantes.Estimated Impact of US Preventive Services Task Force Recommendations on Use and Cost of Statins for Cardiovascular Disease PreventionQ58557264Deprescribing Proton Pump InhibitorsDevelopment of a tool for monitoring the prescribing of antipsychotic medications to people with dementia in general practice: a modified eDelphi consensus studyDREAMeR: Drug use Reconsidered in the Elderly using goal Attainment scales during Medication Review; study protocol of a randomised controlled trialSetback distances for unconventional oil and gas development: Delphi study results
P2860
Q26738924-A2AD5AE1-69C9-4603-9CBA-707477B34738Q28553495-160F863A-A25E-47DE-A352-18BBCBCE5B7BQ30654648-48EE1B93-E099-4ECF-A975-7F4906155DD0Q33675495-16DF535F-245A-42F4-93C1-E5A7746AEA29Q33777994-E8B88FF4-34A7-4BD7-AE00-8697043B1A66Q35935867-0A0195DF-3591-4822-914A-42655E0777F1Q35993718-0C6A4087-D39D-43B9-A33D-1674E4A0381CQ36285871-B5E1F481-6EA3-4B6F-AF32-456F3FEFFE6CQ36410106-7B29D2A0-4EF1-46E4-900A-C111C365DA7BQ36707350-3871C8D7-E64F-422A-BF58-B5A24BAC9E4AQ37056755-2AE01BE3-EB43-484D-AAFC-E39B48911BA7Q38632756-7C13F9E4-3D24-4A4E-BB23-BA86C874DB63Q38855300-25EC9B6A-1138-40DA-9310-7159A1413C94Q39329851-85E293D5-EF94-4C2C-93F8-A431EFC2E5EAQ39426802-1123CB85-5281-4839-A73C-0F2B94323D44Q46189430-824B60AD-C886-47AF-AE75-A31B341DDE4DQ47557869-B10555F8-02DF-4BF4-8DD2-CB91BB1E8A73Q48167336-BE08336C-0B12-4B5E-84E7-A0DAB116B5DCQ48358619-B2D79571-46F5-4738-8397-A224DAFF2AF7Q49874897-D2CF50E6-EA0B-4ED9-BEFC-39B458E21B19Q51150147-ED54F375-D2EB-4FCE-966F-42E6F002EFF5Q53106370-C360BBB6-A9C3-460C-8773-8602D62B1F36Q54259890-2BA558CC-44F0-4BE5-9A4E-896275EAC1A8Q55154616-26EF8794-D514-4A7B-BB2E-BE115DAE18F7Q57172703-E8128F27-4551-447D-9ECF-A4A72366686BQ58557264-8C5EF7ED-D816-4BA8-BFEB-E3FE001983E1Q58557278-6029FB2A-EF21-4294-AED3-B6580366104EQ58694588-747A31B9-3D64-4A71-9ABB-A318A7CBBB50Q58707367-F736D00C-746A-411A-8064-F1266F85170FQ58774919-F6A92AF3-D3B6-4CC7-91F4-44E50976E771
P2860
What are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified delphi process
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
What are priorities for depres ...... ers: a modified delphi process
@ast
What are priorities for depres ...... ers: a modified delphi process
@en
What are priorities for depres ...... ers: a modified delphi process
@nl
type
label
What are priorities for depres ...... ers: a modified delphi process
@ast
What are priorities for depres ...... ers: a modified delphi process
@en
What are priorities for depres ...... ers: a modified delphi process
@nl
prefLabel
What are priorities for depres ...... ers: a modified delphi process
@ast
What are priorities for depres ...... ers: a modified delphi process
@en
What are priorities for depres ...... ers: a modified delphi process
@nl
P2093
P2860
P3181
P1433
P1476
What are priorities for depres ...... ers: a modified delphi process
@en
P2093
Barbara Farrell
Corey Tsang
Hannah Irving
James Conklin
Kevin Pottie
Lalitha Raman-Wilms
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0122246
P407
P577
2015-01-01T00:00:00Z